Skip to main content
Log in

18F-FDG PET/CT is a valuable tool for relapsing polychondritis diagnose and therapeutic response monitoring

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objectives

To retrospectively investigate the role of 18 F–fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) for the diagnosis and therapeutic response in relapsing polychondritis (RP) patients.

Methods

18F-FDG PET/CT findings were reviewed in six RP patients. The initial scans were performed for all patients, follow-up scans were performed during steroid therapy for five patients. Changes in the abnormal lesions and the maximal standard uptake value (SUVmax) were analyzed.

Results

The initial PET/CT scans revealed intense FDG uptake in the cartilages for all six patients. The lesions of abnormal FDG uptake were tracheal/bronchial cartilage (n = 4), costicartilage (n = 4), nasal cartilage (n = 3), cricoid cartilage (n = 3), auricular cartilage (n = 3), arytenoid cartilage (n = 3), thyroid cartilage (n = 2), hyoid cartilage (n = 1) and mediastinum lymph node (n = 1). The mean visual score and the mean SUVmax were 2.96 ± 0.20 and 4.10 ± 0.6. The intense uptake reduced or disappeared during steroid therapy for five patients, the mean visual score and the mean SUVmax were 1.58 ± 1.4 and 1.51 ± 1.4.

Conclusions

18F-FDG PET/CT enables the acquisition of both morphologic and glucose metabolic of the related cartilage structures. It plays a valuable role in assessing almost all cartilage and detecting RP, which is a better selection of a biopsy site as well as therapeutic response monitoring.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine. 1976;55(3):193–215.

    Article  PubMed  CAS  Google Scholar 

  2. Mathew SD, Battafarano DF, Morris MJ. Relapsing polychondritis in the department of defense population and review of the literature. Semin Arthritis Rheum. 2012;42(1):70–83.

    Article  PubMed  Google Scholar 

  3. Lahmer T, Treiber M, von Werder A, Foerger F, Knopf A, Heemann U, et al. Relapsing polychondritis: an autoimmune disease with many faces. Autoimmun Rev. 2010;9(8):540–6.

    Article  PubMed  CAS  Google Scholar 

  4. Kent PD, Michet CJ, Luthra HS. Relapsing polychondritis. Curr Opin Rheumatol. 2004;16(1):56–61.

    Article  PubMed  Google Scholar 

  5. Behar JV, Choi YW, Hartman TA, Allen NB, McAdams HP. Relapsing polychondritis affecting the lower respiratory tract. AJR Am J Roentgenol. 2002;178:173–7.

    Article  PubMed  Google Scholar 

  6. Shi XH, Zhang FC, Chen LB, Ouyang M. The value of 99mTc methylene diphosphonate bone scintigraphy in diagnosing relapsing polychondritis. Chin Med J (Engl). 2006;119(13):1129–32.

    Google Scholar 

  7. Okuyama C, Ushijima Y, Sugihara H, Okitsu S, Ito H, Maeda T. Increased subglottic gallium uptake in relapsing polychondritis. J Nucl Med. 1998;39:1977–9.

    PubMed  CAS  Google Scholar 

  8. Czernin J, Benz MR, Allen-Auerb ach MS. PET/CT imaging: the incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination. Eur J Radiol. 2010;73:470–80.

    Article  PubMed  Google Scholar 

  9. Sugawara Y, Braun DK, Kison PV, Russo JE, Zasadny KR, Wahl RL. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med. 1998;25:1238–43.

    Article  PubMed  CAS  Google Scholar 

  10. Signore A, Glaudemans AW. The molecular imaging approach to image infections and inflammation by nuclear medicine techniques. Ann Nucl Med. 2011;25(10):681–700.

    Article  PubMed  Google Scholar 

  11. Nishiyama Y, Yamamoto Y, Dobashi H, Kameda T, Satoh K, Ohkawa M. [18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis. J Comput Assist Tomogr. 2007;31:381–3.

    Article  PubMed  Google Scholar 

  12. De Geeter F, Vandecasleele SJ. Fluorodeoxyglucose PET in relapsing polychondritis. N Engl J Med. 2008;358(5):536–7.

    Article  PubMed  Google Scholar 

  13. Yokoyama T, Koyama N, Kodama K, Hagiwara K, Kanazawa M. F-fluorodeoxyglucose positron emission tomography for relapsing polychondritis as a diagnostic approach and evaluation of disease activity. BMJ Case Rep. 2009;2009:1591.

    Google Scholar 

  14. Sato M, Hiyama T, Abe T, Ito Y, Yamaguchi S, Uchiumi K, et al. F-18 FDG PET/CT in relapsing polychondritis. Ann Nucl Med. 2010;24:687–90.

    Article  PubMed  Google Scholar 

  15. Czepczyński R, Guzikowska-Ruszkowska I, Wyszomirska A. Relapsing polychondritis detected in PET/CT. Eur J Nucl Med Mol Imaging. 2012;39(8):1366–7.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Deng H, Chen P, Wang L, Li X, Yi J. Relapsing polychondritis on PET/CT. Clin Nucl Med. 2012;37(7):712–5.

    Article  PubMed  Google Scholar 

  17. Damiani JM, Levine HL. Relapsing polychondritis–report of ten cases. Laryngoscope. 1979;89(6 Pt 1):929–46.

    PubMed  CAS  Google Scholar 

  18. Roedl JB, Colen RR, King K, Fischman AJ, Mueller PR, Blake MA. Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions. AJR Am J Roentgenol. 2008;191(2):515–21.

    Article  PubMed  Google Scholar 

  19. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. Ann Thorac Surg. 2005;79(3):984–9.

    Article  PubMed  Google Scholar 

  20. Koyama K, Okamura T, Kawabe J, Nakata B, Chung KH, Ochi H, et al. Diagnostic usefulness of FDG PET for pancreatic mass lesions. Ann Nucl Med. 2001;15(3):217–24.

    Article  PubMed  CAS  Google Scholar 

  21. Tillie-Leblond I, Wallaert B, Leblond D, Salez F, Perez T, Remy-Jardin M, et al. Respiratory involvement in relapsing polychondritis. Clinical, functional, endoscopic, and radiographic evaluations. Medicine (Baltimore). 1998;77(3):168–76.

    Article  CAS  Google Scholar 

  22. Faix LE, Branstetter BF 4th. Uncommon CT findings in relapsing polychondritis. AJNR Am J Neuroradiol. 2005;26(8):2134–6.

    PubMed  Google Scholar 

  23. Diederichs CG, Staib L, Glatting G, Beger HG, Reske SN. FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med. 1998;39:103.

    Google Scholar 

Download references

Acknowledgments

The authors would like to thank Yongfeng Luo for his assistance in proof reading of the present manuscript.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shiyue Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, J., Li, S., Zeng, Y. et al. 18F-FDG PET/CT is a valuable tool for relapsing polychondritis diagnose and therapeutic response monitoring. Ann Nucl Med 28, 276–284 (2014). https://doi.org/10.1007/s12149-014-0805-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-014-0805-1

Keywords

Navigation